CMTM5 | CKLF-like MARVEL transmembrane domain containing 5 | Predicted membrane proteins
| | | | | Tissue enriched |
CMTM8 | CKLF-like MARVEL transmembrane domain containing 8 | Predicted membrane proteins
| | | | | Mixed |
CNGA3 | Cyclic nucleotide gated channel alpha 3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Mixed |
CNNM1 | Cyclin and CBS domain divalent metal cation transport mediator 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
CNNM3 | Cyclin and CBS domain divalent metal cation transport mediator 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
CNNM4 | Cyclin and CBS domain divalent metal cation transport mediator 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
COX18 | COX18 cytochrome C oxidase assembly factor | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
CRLS1 | Cardiolipin synthase 1 | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
CX3CR1 | Chemokine (C-X3-C motif) receptor 1 | Disease related genes G-protein coupled receptors Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
CXCR2 | Chemokine (C-X-C motif) receptor 2 | Cancer-related genes CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CYB561 | Cytochrome b561 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
CYB561D1 | Cytochrome b561 family, member D1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
CYBA | Cytochrome b-245, alpha polypeptide | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
CYBRD1 | Cytochrome b reductase 1 | Predicted membrane proteins
| | | | | Expressed in all |
CYP2U1 | Cytochrome P450, family 2, subfamily U, polypeptide 1 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Mixed |
DAGLB | Diacylglycerol lipase, beta | Predicted membrane proteins
| | | | | Expressed in all |
DEGS1 | Delta(4)-desaturase, sphingolipid 1 | Predicted membrane proteins
| | | | | Expressed in all |
DEGS2 | Delta(4)-desaturase, sphingolipid 2 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DERL1 | Derlin 1 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
DERL2 | Derlin 2 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
DERL3 | Derlin 3 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
DGAT1 | Diacylglycerol O-acyltransferase 1 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
DHCR7 | 7-dehydrocholesterol reductase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
DIP2C | DIP2 disco-interacting protein 2 homolog C (Drosophila) | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
DNAJC13 | DnaJ (Hsp40) homolog, subfamily C, member 13 | Predicted membrane proteins
| | | | | Expressed in all |
DNAJC14 | DnaJ (Hsp40) homolog, subfamily C, member 14 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
DOLPP1 | Dolichyldiphosphatase 1 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
DPY19L1 | Dpy-19-like 1 (C. elegans) | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
DRD2 | Dopamine receptor D2 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
EBPL | Emopamil binding protein-like | Predicted membrane proteins
| | | | | Expressed in all |
EI24 | Etoposide induced 2.4 | Cancer-related genes Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ELOVL5 | ELOVL fatty acid elongase 5 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ELOVL7 | ELOVL fatty acid elongase 7 | Enzymes Predicted membrane proteins
| | | | | Mixed |
EMP1 | Epithelial membrane protein 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
FA2H | Fatty acid 2-hydroxylase | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
FADS1 | Fatty acid desaturase 1 | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
FADS3 | Fatty acid desaturase 3 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
FAIM2 | Fas apoptotic inhibitory molecule 2 | Predicted membrane proteins
| | | | | Tissue enriched |
FAM134A | Family with sequence similarity 134, member A | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
FAM189A1 | Family with sequence similarity 189, member A1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FAM189B | Family with sequence similarity 189, member B | Predicted membrane proteins
| | | | | Expressed in all |
FAM26D | Family with sequence similarity 26, member D | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
FAM26E | Family with sequence similarity 26, member E | Predicted membrane proteins
| | | | | Mixed |
FAM26F | Family with sequence similarity 26, member F | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
FAM57A | Family with sequence similarity 57, member A | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
FAXDC2 | Fatty acid hydroxylase domain containing 2 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
FPR1 | Formyl peptide receptor 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GABRA1 | Gamma-aminobutyric acid (GABA) A receptor, alpha 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
GABRA2 | Gamma-aminobutyric acid (GABA) A receptor, alpha 2 | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
GABRA3 | Gamma-aminobutyric acid (GABA) A receptor, alpha 3 | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |